Charles Zhu

Stock Analyst at Guggenheim

(2.73)
# 2,043
Out of 5,044 analysts
27
Total ratings
52.17%
Success rate
21.76%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Charles Zhu

Tango Therapeutics
Oct 24, 2025
Maintains: Buy
Price Target: $10$12
Current: $7.83
Upside: +53.26%
Merus
Sep 30, 2025
Downgrades: Market Perform
Price Target: $97
Current: $94.81
Upside: +2.31%
Crescent Biopharma
Jun 18, 2025
Initiates: Outperform
Price Target: $22
Current: $12.50
Upside: +76.00%
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.78
Upside: -
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $1.69
Upside: +610.06%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $102.97
Upside: -45.62%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $5.20
Upside: +323.08%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $16.00
Upside: +62.50%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $32.18
Upside: -0.56%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $19.38
Upside: -27.76%